Impact of Nicotine on Retinal Vascularization
TABARET
1 other identifier
observational
58
1 country
1
Brief Summary
The main hypothesis is the nicotine is associated with a modification of retinal micro-vascularization. Patients will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to medical history, oral contraceptive intake and nicotine consumption via cigarette or e-cigarette data will be collected. The objective is to seek an association between retinal vascular density and inhaled nicotine intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2019
CompletedFirst Posted
Study publicly available on registry
May 28, 2019
CompletedStudy Start
First participant enrolled
July 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2022
CompletedFebruary 17, 2023
February 1, 2023
3.4 years
May 24, 2019
February 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Density of retinal vascular Plexus (quantitative variable expressed as a percentage) using OCT-A.
At the inclusion consultation
Study Arms (3)
smokers
vapers
non smokers/non vapers
Interventions
Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception
Eligibility Criteria
People presenting to an ophthalmologic consultation at the Foundation Rothschild will be included in one of the 3 groups: smokers, non-smokers/non-vapers or vapers if they meet the inclusion and non-inclusion criteria
You may qualify if:
- For group of smokers: Patient reporting active smoking for at least 3 months and at least 1 cigarette per day on average over a week
- For group of vapers : Patient using exclusively the electronic cigarette with a nicotine level of more than 6mg/ml for at least 3 months and at least 1 times per day on average over a week.
- For group of no-smokers no-vapersNon-smoking and no vaping, for more than 6 months
- Caffeine intake within 2 hours prior to the OCT-A exam
- ametropia greater than + 3 dioptres of hyperopia or-3 dioptres of myopia
- astigmatism greater than 2 dioptres
- Known retinal or retina vascular pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation A de Rothschild
Paris, 75019, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2019
First Posted
May 28, 2019
Study Start
July 17, 2019
Primary Completion
December 2, 2022
Study Completion
December 2, 2022
Last Updated
February 17, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share